The Current Ratio as of September 2024 (TTM) for Geron Corporation (GERN) is 3.61

According to Geron Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 3.61. This represents a change of 1.71% compared to the average of 3.54 of the last 4 quarters.

Geron Corporation (GERN) Historical Current Ratio (quarterly & annually)

How has GERN Current Ratio performed in the past?

The mean historical Current Ratio of Geron Corporation over the last ten years is 9.37. The current 3.61 Current Ratio has changed 3.75% with respect to the historical average. Over the past ten years (40 quarters), GERN's Current Ratio was at its highest in in the September 2018 quarter at 37.80. The Current Ratio was at its lowest in in the December 2022 quarter at 2.35.

Geron Corporation (GERN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Geron Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Geron Corporation (GERN) Average Current Ratio

How has GERN Current Ratio performed in the past?

The current Current Ratio of Geron Corporation (GERN) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Geron Corporation (GERN) Current Ratio vs. Peers

How is GERN’s Current Ratio compared to its peers?

Geron Corporation’s Current Ratio is less than Viking Therapeutics, Inc. (0), less than TG Therapeutics, Inc. (37.69), greater than X4 Pharmaceuticals, Inc. (3.58), less than PDS Biotechnology Corporation (6.07), less than Madrigal Pharmaceuticals, Inc. (3.84), less than Zura Bio Limited (8.72), less than Enveric Biosciences, Inc. (12.57), less than eFFECTOR Therapeutics, Inc. (7.37), greater than Immix Biopharma, Inc. (1.03), less than Elevation Oncology, Inc. (7.00), less than Sarepta Therapeutics, Inc. (41.10), less than Hepion Pharmaceuticals, Inc. (3.90), less than PTC Therapeutics, Inc. (5.62), greater than CohBar, Inc. (2.23), less than Ocean Biomedical, Inc. (4.16), greater than AVROBIO, Inc. (0.03), less than null (26.17),

Build a custom stock screener for Geron Corporation (GERN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Geron Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Geron Corporation (GERN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Geron Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.